Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
FDA clears investigational new drug application for novel GA treatment
The FDA granted clearance to an investigational new drug application for EA-2351, a novel compound for the treatment of geographic atrophy, according to a press release from Endogena Therapeutics.
ANX007 for geographic atrophy receives priority medicine designation from EMA
The European Medicines Agency granted priority medicine designation to ANX007 for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Annexon Biosciences.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Real-world data show positive, stable outcomes of faricimab in wet AMD, DME
In this Healio Video Perspective, Arshad M. Khanani, MD, MA, FASRS, speaks about the positive real-world outcomes of faricimab in the TRUCKEE and TAHOE studies, presented at the Euretina congress in Amsterdam.
VIDEO: ONL1204 demonstrates promising results in geographic atrophy
NEW YORK — In this Healio Video Perspective from OSN New York’s Disruptive Innovations Symposium, David Esposito, CEO of ONL Therapeutics, discusses results of ONL1204 in geographic atrophy.
Two-year study outcomes show increasing positive effect of pegcetacoplan in GA
Two-year results from the phase 3 OAKS and DERBY studies evaluating Syfovre for geographic atrophy showed clinically meaningful reduction of lesion growth with increasing effect over time.
VIDEO: AVD-104 may offer next-generation treatment for geographic atrophy
In this Healio Video Perspective, Baruch D. Kuppermann, MD, PhD, speaks about AVD-104, a novel approach to the management of nonexudative macular degeneration, presented at the Euretina congress in Amsterdam.
VIDEO: Real-world studies show benefits of faricimab in neovascular AMD
In this Healio Video Perspective, Theodore Leng, MD, FACS, discusses the real-world use of faricimab for neovascular age-related macular degeneration.
VIDEO: Researchers investigate tyrosine kinase inhibitors for wet AMD
In this Healio Video Perspective, Sophie J. Bakri, MD, discusses data presented at the Retina Society meeting that investigated the antiangiogenic profiles of three tyrosine kinase inhibitors: vorolanib, axitinib and sunitinib.
VIDEO: Case supports intravitreal steroids as option for melanoma-associated retinopathy
In this Healio Video Perspective, Dilraj Grewal, MD, discusses a case of melanoma-associated retinopathy in a patient recalcitrant to treatment with immunosuppressive immunomodulator agents.
VIDEO: Post hoc analyses begin to show less vision loss with GA treatments
NEW YORK — In this Healio Video Perspective from OSN New York Retina, Carl D. Regillo, MD, discusses his presentation on the latest data from the phase 3 studies of pegcetacoplan and avacincaptad pegol for treating geographic atrophy.